This inventor holds 2 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Tel Aviv University, Technion Research & Development Foundation Ltd. Active years: 2021-2023.
Company Filing History:
2 out of 841 
1 out of 1,003 
Years Active: 2021-2023
Title: Nisim Perets: Innovator in Neurological Treatments
Introduction
Nisim Perets is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological diseases. With a total of 2 patents, his work focuses on innovative methods to address complex health issues.
Latest Patents
Nisim Perets holds two recent patents that showcase his innovative approach. The first patent, titled "Vesicles comprising a PTEN inhibitor and uses of same," provides pharmaceutical compositions that include membrane vesicles, such as extracellular vesicles and exosomes, loaded with an exogenous Phosphatase and tensin homolog (PTEN) inhibitor. This invention outlines methods for treating neurological diseases, disorders, or conditions using these extracellular vesicles. The second patent, "Mesenchymal cell-derived exosomes to treat neurological disorders," discloses a method for treating neurological diseases, including autism, by administering a therapeutically effective amount of microparticles derived from mesenchymal stem cells.
Career Highlights
Throughout his career, Nisim Perets has been associated with prestigious institutions such as Tel Aviv University and the Technion Research & Development Foundation Ltd. His work at these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Nisim has collaborated with esteemed colleagues, including Daniel Offen and Shulamit Levenberg. These partnerships have further enriched his research and innovation in the field of neurological treatments.
Conclusion
Nisim Perets is a prominent inventor whose work in developing innovative treatments for neurological disorders is noteworthy. His patents reflect a commitment to advancing medical science and improving patient outcomes.